Hui Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hui Liu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bi Lei
Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, Luzhou, China
1 shared publication Bin Liao
Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China
1 shared publication- Bingxue Chen
Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, Luzhou, China
1 shared publication Changyi Wang
Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China
1 shared publication- Chao Hou
Department of Ultrasound, the Affiliated Hospital, Southwest Medical University, Luzhou, China
1 shared publication Fengxu Yu
Department of Cardiovascular Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, China
1 shared publication
Latest Publications
- Open Access
- 19 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (38) , e44671
The immune system’s mediation of the protective effect of Parabacteroides against obesity: A Mendelian randomization study
Parabacteroides, a core component of the human gut microbiota, is closely associated with various diseases. While some studies have observed a decrease in the abundance of Parabacteroides in patients with obesity, the specific relationship and underlying mechanisms remain unclear. This study primarily employed 2-sample 2-step Mendelian randomization (MR), utilizing genetic data from 3 large publicly available genome-wide association studies. Within this framework, we applied 2-sample MR to assess the causal impact of Parabacteroides abundance in stool on obesity and used reverse MR to ensure the unidirectionality of the causal relationship. Additionally, we attempted to use 2-step MR to investigate the potential mediating role of immune cell phenotypes in this relationship. The results of the inverse variance weighted method indicated that Parabacteroides abundance in stool was negatively associated with obesity, with an odds ratio of 0.94 (95% CI: 0.88, 0.99). Additionally, 3 immune cell phenotypes—relative count-CD62L‐ CD86+ myeloi DC %DC (8.4%), MFI-CD25 on B cells (8.9%), and MFI-CD4 on activated and secreting Tregs (4.7%)—played a mediating role in this relationship. Our research findings suggest that elevated Parabacteroides abundance in stool may have a potential protective effect against obesity, with the immune system playing a mediating role in this relationship.
- 19 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (38) , e44671
Open AccessThe immune system’s mediation of the protective effect of Parabacteroides against obesity: A Mendelian randomization study
Parabacteroides, a core component of the human gut microbiota, is closely associated with various diseases. While some studies have observed a decrease in the abundance of Parabacteroides in patients with obesity, the specific relationship and underlying mechanisms remain unclear. This study primarily employed 2-sample 2-step Mendelian randomization (MR), utilizing genetic data from 3 large publicly available genome-wide association studies. Within this framework, we applied 2-sample MR to assess the causal impact of Parabacteroides abundance in stool on obesity and used reverse MR to ensure the unidirectionality of the causal relationship. Additionally, we attempted to use 2-step MR to investigate the potential mediating role of immune cell phenotypes in this relationship. The results of the inverse variance weighted method indicated that Parabacteroides abundance in stool was negatively associated with obesity, with an odds ratio of 0.94 (95% CI: 0.88, 0.99). Additionally, 3 immune cell phenotypes—relative count-CD62L‐ CD86+ myeloi DC %DC (8.4%), MFI-CD25 on B cells (8.9%), and MFI-CD4 on activated and secreting Tregs (4.7%)—played a mediating role in this relationship. Our research findings suggest that elevated Parabacteroides abundance in stool may have a potential protective effect against obesity, with the immune system playing a mediating role in this relationship.
- 1 April 2025
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (7) , 4417-4429
Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts
Mesenchymal stem cells (MSCs) have been shown to attenuate myocardial fibrosis after myocardial infarction by secreting various bioactive molecules that positively affect the failing heart. We hypothesized that serum factors play an active role in the activation of bone marrow MSCs after myocardial infarction and explored the effect of differential exocytosis on cardiac repair after infarct serum preconditioning by examining whether exosomes derived from MSCs have a positive effect on cardiac fibrosis. Bone marrow MSCs were pretreated by collecting rat myocardial infarction serum, followed by the collection of myocardial infarction serum exosomes (MIS-EXO). In vivo, intramyocardial injection of exosomes was performed 30 min after permanent ligation of the anterior descending branches of Sprague Dawley rats, and echocardiography was performed at different time intervals to evaluate cardiac function. Hearts were sampled 4 weeks later, and the degree of myocardial fibrosis and inflammatory response were evaluated using hematoxylin and eosin and Masson’s trichrome staining. Treatment with common culture-derived exosomes (CON-EXO) improved cardiac function and myocardial fibrosis after myocardial infarction in rats compared with the myocardial infarction group. In vitro, the antifibrotic effects of different exosomes on tumor growth factor-β-induced fibroblast fibrosis model were assessed by protein blotting, qPCR, and immunofluorescence. Compared with CON-EXO, MIS-EXO exerted superior therapeutic effects in terms of anti-inflammation, improvement of left ventricular function, and reduction of fibrosis. Infarct serum pretreatment with bone marrow mesenchymal stem cell-derived exosomes enhances the anti-cardiac fibrosis effect in rats after myocardial infarction.
- 1 April 2025
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (7) , 4417-4429
Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts
Mesenchymal stem cells (MSCs) have been shown to attenuate myocardial fibrosis after myocardial infarction by secreting various bioactive molecules that positively affect the failing heart. We hypothesized that serum factors play an active role in the activation of bone marrow MSCs after myocardial infarction and explored the effect of differential exocytosis on cardiac repair after infarct serum preconditioning by examining whether exosomes derived from MSCs have a positive effect on cardiac fibrosis. Bone marrow MSCs were pretreated by collecting rat myocardial infarction serum, followed by the collection of myocardial infarction serum exosomes (MIS-EXO). In vivo, intramyocardial injection of exosomes was performed 30 min after permanent ligation of the anterior descending branches of Sprague Dawley rats, and echocardiography was performed at different time intervals to evaluate cardiac function. Hearts were sampled 4 weeks later, and the degree of myocardial fibrosis and inflammatory response were evaluated using hematoxylin and eosin and Masson’s trichrome staining. Treatment with common culture-derived exosomes (CON-EXO) improved cardiac function and myocardial fibrosis after myocardial infarction in rats compared with the myocardial infarction group. In vitro, the antifibrotic effects of different exosomes on tumor growth factor-β-induced fibroblast fibrosis model were assessed by protein blotting, qPCR, and immunofluorescence. Compared with CON-EXO, MIS-EXO exerted superior therapeutic effects in terms of anti-inflammation, improvement of left ventricular function, and reduction of fibrosis. Infarct serum pretreatment with bone marrow mesenchymal stem cell-derived exosomes enhances the anti-cardiac fibrosis effect in rats after myocardial infarction.
- Open Access
- 1 August 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (8) , 5814-5830
Comparison of the diagnostic performance of contrast-enhanced ultrasound and high-resolution magnetic resonance imaging in the evaluation of histologically defined vulnerable carotid plaque: a systematic review and meta-analysis
Background: Vulnerable carotid plaque is closely associated with ischemic stroke. Contrast-enhanced ultrasound (CEUS) and high-resolution magnetic resonance imaging (HR-MRI) are two imaging modalities capable of assessing the vulnerability of carotid plaques. This systematic review aimed to compare the diagnostic performance of CEUS and HR-MRI in the evaluation of histologically defined vulnerable carotid plaques. Methods: A systematic literature search with predefined search terms was performed on PubMed, the Cochrane library, Embase, and Web of Science from January 2001 to December 2023. Studies that evaluated the diagnostic accuracy of vulnerable carotid plaques confirmed by histology with CEUS and/or HR-MRI were included. The pooled values were calculated using a random-effects meta-analysis to determine diagnostic power. Results: This analysis included a total of 839 patients from 20 studies comprising 1,357 HR-MRI plaques and CEUS 504 plaques. With the reference to histological results, all nine CEUS studies focused on the detection of intraplaque neovascularization (IPN), and three studies also examined morphological changes or ulcerated plaques; meanwhile, among the HR-MRI studies, seven predominantly focused on identifying intraplaque hemorrhage (IPH) and three mainly examined lipid-rich necrotic cores (LRNCs). The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and the area under the curve (AUC) for CEUS studies were 0.85 [95% confidence interval (CI): 0.81–0.89], 0.76 (95% CI: 0.69–0.83), 3.41 (95% CI: 1.68–6.94), 0.14 (95% CI: 0.05–0.38), 27.68 (95% CI: 5.78–132.62), and 0.89 [standard error (SE) 0.06], respectively; for HR-MRI, these values were 0.88 (95% CI: 0.85–0.90), 0.89 (95% CI: 0.86–0.92), 7.49 (95% CI: 3.28–17.09), 0.17 (95% CI: 0.12–0.24), 49.13 (95% CI: 23.87–101.11), and 0.94 (SE 0.01), respectively. The difference in AUC between the two modalities was not statistically significant (Z=0.82; P=0.68). Conclusions: CEUS and HR-MRI are valuable noninvasive diagnostic tools for identifying histologically confirmed vulnerable carotid plaques and demonstrate similar diagnostic performance. CEUS is more capable of detecting IPN and morphological changes, while HR-MRI is more suited to classifying IPH and LRNCs.
- 1 August 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (8) , 5814-5830
Open AccessComparison of the diagnostic performance of contrast-enhanced ultrasound and high-resolution magnetic resonance imaging in the evaluation of histologically defined vulnerable carotid plaque: a systematic review and meta-analysis
Background: Vulnerable carotid plaque is closely associated with ischemic stroke. Contrast-enhanced ultrasound (CEUS) and high-resolution magnetic resonance imaging (HR-MRI) are two imaging modalities capable of assessing the vulnerability of carotid plaques. This systematic review aimed to compare the diagnostic performance of CEUS and HR-MRI in the evaluation of histologically defined vulnerable carotid plaques. Methods: A systematic literature search with predefined search terms was performed on PubMed, the Cochrane library, Embase, and Web of Science from January 2001 to December 2023. Studies that evaluated the diagnostic accuracy of vulnerable carotid plaques confirmed by histology with CEUS and/or HR-MRI were included. The pooled values were calculated using a random-effects meta-analysis to determine diagnostic power. Results: This analysis included a total of 839 patients from 20 studies comprising 1,357 HR-MRI plaques and CEUS 504 plaques. With the reference to histological results, all nine CEUS studies focused on the detection of intraplaque neovascularization (IPN), and three studies also examined morphological changes or ulcerated plaques; meanwhile, among the HR-MRI studies, seven predominantly focused on identifying intraplaque hemorrhage (IPH) and three mainly examined lipid-rich necrotic cores (LRNCs). The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and the area under the curve (AUC) for CEUS studies were 0.85 [95% confidence interval (CI): 0.81–0.89], 0.76 (95% CI: 0.69–0.83), 3.41 (95% CI: 1.68–6.94), 0.14 (95% CI: 0.05–0.38), 27.68 (95% CI: 5.78–132.62), and 0.89 [standard error (SE) 0.06], respectively; for HR-MRI, these values were 0.88 (95% CI: 0.85–0.90), 0.89 (95% CI: 0.86–0.92), 7.49 (95% CI: 3.28–17.09), 0.17 (95% CI: 0.12–0.24), 49.13 (95% CI: 23.87–101.11), and 0.94 (SE 0.01), respectively. The difference in AUC between the two modalities was not statistically significant (Z=0.82; P=0.68). Conclusions: CEUS and HR-MRI are valuable noninvasive diagnostic tools for identifying histologically confirmed vulnerable carotid plaques and demonstrate similar diagnostic performance. CEUS is more capable of detecting IPN and morphological changes, while HR-MRI is more suited to classifying IPH and LRNCs.